- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2014
- Public Summary Document (PSD) July 2014 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2014 PBAC Meeting - Word
Umeclidinium (as bromide) – July 2014
UMECLIDINIUM (as BROMIDE), 62.5 microgram/actuation, inhalation: powder for, 30 actuations, Incruse® Ellipta®, GlaxoSmithKline Australia Pty Ltd
Last updated
8 November 2023